Connection

Christopher Koivisto to PTEN Phosphohydrolase

Back to Details
This is a "connection" page, showing publications Christopher Koivisto has written about PTEN Phosphohydrolase.
Christopher Koivisto
Connection Strength
0.949
PTEN Phosphohydrolase
  1. Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia. 2020 10; 22(10):484-496.
    View in: PubMed
    Score: 0.652
  2. Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. Oncogene. 2022 04; 41(15):2187-2195.
    View in: PubMed
    Score: 0.181
  3. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev. 2015 Aug 15; 29(16):1707-20.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.